The company makes the Argus II device that helps ER patients to regain partial vision by transmitting computer processed video images to an array of electrodes placed on the retinal surface.
There are a thousand reasons it is temporary hype, and potentially pump and dump scheme. The recent price movement is unfounded.
The hype may well continue. Patience and tenacity are required.